Loading clinical trials...
Loading clinical trials...
Erdheim-Chester Disease (ECD) is a rare form of histiocytosis characterized by the proliferation of blood cells, known as histiocytes, which infiltrate various organs and tissues, often causing irreve...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Meyer Children's Hospital IRCCS
NCT07454343 · Erdheim-Chester Disease (ECD)
NCT06712810 · Hematopoietic and Lymphatic System Neoplasm, Histiocytic Sarcoma, and more
NCT04079179 · Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma, and more
NCT02285582 · Rare Histiocytic Disorders (RHDs), Erdheim-Chester Disease (ECD), and more
NCT06332183 · Erdheim-Chester Disease
Meyer Children's Hospital IRCCS
Florence, Firenze
AOU Parma
Parma
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions